• English
  • Sign In
  • Contact Us


Fill in The Form to View Video

Challenges and role of serology in the next phase of COVID-19 responses

Learn about COVID-19 and the importance of serology investigation in viral disease outbreak.


  1. Toelzer, C. et al . Unexpected free fatty acid binding pocket in the cryo-EM structure of SARS-CoV-2 spike protein. bioRxiv doi: 10.1101/2020.06.18.158584(2020).
  2. Tan C.W. et al. A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2–spike protein–protein interaction. Nat. Biotechnol. (2020).
  3. Le Bert, N. et al. SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls. Nature https://doi.org/10.1038/s41586-020-2550-z. (2020).
  4. Bond K. et al. Evaluation of Serological Tests for SARS-CoV-2: Implications for Serology Testing in a Low-Prevalence Setting. The Journal of Infectious Diseases. (2020).
  5. Peiris M. et al. Evaluation of a SARS-CoV-2 surrogate virus neutralization test for detection of antibody in human, canine, cat and hamster sera. medRxiv doi:10.1101/2020.07.28.20163592. (2020).
  6. Addetia A. et al. Neutralizing antibodies correlate with protection from SARS-CoV-2 in humans during a fishery vessel outbreak with high attack rate. medRxiv doi:10.1101/2020.08.13.20173161. (2020).
  7. McGregor R, et al. Collaborative networks enable the rapid establishment of serological assays for SARS-CoV-2 during nationwide lockdown in New Zealand. PeerJ 8:e9863 DOI 10.7717/peerj.9863. (2020).
  8. Chen W, et al. SARS-CoV-2 neutralizing antibody levels are correlated with severity of COVID-19 pneumonia. Biomedicine & Pharmacotherapy, volume 130, 2020, 110629.
  9. Woon, Y. et al. Serology surveillance of anti-SARS-CoV-2 antibodies among asymptomatic healthcare workers in Malaysian healthcare facilities designated for COVID-19 care. Research Square: 10.21203/rs.3.rs-37132/v1(2020).
  10. Myer, B. et al. Validation and clinical evaluation of a SARS-CoV-2 Surrogate Virus Neutralization Test (sVNT). medRxiv: 10.1101/2020.09.21.20191288(2020)


More FAQs